Krystal Biotech (NASDAQ:KRYS) said it has generated positive interim clinical results for its inhaled cystic fibrosis (CF) ...
Krystal Biotech reports positive clinical data for KB408 and KB407, demonstrating safety and efficacy in AATD and cystic fibrosis patients. Krystal Biotech, Inc. has announced promising clinical ...
Earlier this week, Krystal Biotech reported positive interim data from the highest-dose cohort of its Phase 1 CORAL-1 trial, ...
BEIJING, Jan. 20, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd., a leading biotechnology company, today announced ...
Clinical Trials Arena on MSN
Genespire to take rare disease gene therapy to clinic in 2026
While a majority of the therapies currently in development are life-long treatments, Genespire is taking a different approach ...
Single cell gene expression studies often rely on single-cell RNA sequencing (scRNA-seq) alone. While scRNA-seq reveals which genes are turned on, it does not capture protein expression or changes to ...
Researchers at the Jackson Laboratory (JAX), the Broad Institute of MIT and Harvard, and Yale University, have used artificial intelligence (AI) to design thousands of new DNA switches that can ...
News-Medical.Net on MSN
Gene regulators could restore the aging body's ability to self-repair
As we age, we don't recover from injury or illness like we did when we were young. But new research from UCSF has found gene ...
At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results